Back
Cell Source, Inc. 10K Form
Buy
51
CLCS
Cell Source, Inc.
Last Price:
$0.8500
Seasonality Move:
14.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLCS News And Ratings
See the #1 stock for the next 7 days that we like better than CLCS
CLCS Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-639K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.44 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.15000 |
|---|---|
| Net Income (TTM): | $-5.2M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Cell Source, Inc. Earnings Forecast
Key Cell Source, Inc. Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 6 years.
Cell Source, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLCS |
| Website: | cell-source.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLCS Technical Analysis vs Fundamental Analysis
Buy
51
Cell Source, Inc. (CLCS)
is a Buy
Is Cell Source, Inc. a Buy or a Sell?
-
Cell Source, Inc. stock is rated a BuyThe current Cell Source, Inc. [CLCS] share price is $0.8500. The Score for CLCS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.